3.55
price down icon3.27%   -0.12
after-market Dopo l'orario di chiusura: 3.56 0.01 +0.28%
loading
Precedente Chiudi:
$3.67
Aprire:
$3.68
Volume 24 ore:
153.52K
Relative Volume:
0.69
Capitalizzazione di mercato:
$138.14M
Reddito:
$1.50M
Utile/perdita netta:
$-81.41M
Rapporto P/E:
-0.5453
EPS:
-6.51
Flusso di cassa netto:
$-43.75M
1 W Prestazione:
-22.99%
1M Prestazione:
+38.67%
6M Prestazione:
+11.29%
1 anno Prestazione:
+96.13%
Intervallo 1D:
Value
$3.48
$3.7079
Intervallo di 1 settimana:
Value
$3.40
$4.79
Portata 52W:
Value
$1.32
$5.00

Leap Therapeutics Inc Stock (LPTX) Company Profile

Name
Nome
Leap Therapeutics Inc
Name
Telefono
617 252 4343
Name
Indirizzo
47 THORNDIKE STREET, CAMBRIDGE, MA
Name
Dipendente
54
Name
Cinguettio
@LeapTherapeutic
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
LPTX's Discussions on Twitter

Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-10-04 Iniziato Mizuho Buy
2021-06-04 Ripresa Robert W. Baird Outperform
2020-06-29 Iniziato Piper Sandler Overweight
2020-02-11 Iniziato Robert W. Baird Outperform
2019-11-15 Downgrade Raymond James Outperform → Mkt Perform
2019-09-13 Ripresa Raymond James Outperform
2017-03-07 Iniziato Ladenburg Thalmann Buy
Mostra tutto

Leap Therapeutics Inc Borsa (LPTX) Ultime notizie

pulisher
Nov 02, 2024

Sermonix Pharmaceuticals’ Lasofoxifene Is Well Tolerated, - GlobeNewswire

Nov 02, 2024
pulisher
Nov 01, 2024

DKN-01 With Tislelizumab and Chemotherapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma - The ASCO Post

Nov 01, 2024
pulisher
Oct 27, 2024

Leap Therapeutics, Inc. (NASDAQ:LPTX) Sees Large Decline in Short Interest - MarketBeat

Oct 27, 2024
pulisher
Oct 27, 2024

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance

Oct 27, 2024
pulisher
Oct 25, 2024

Payment processor Finix secures $75m in Series C funding - Electronic Payments International

Oct 25, 2024
pulisher
Oct 18, 2024

Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy - FiercePharma

Oct 18, 2024
pulisher
Oct 17, 2024

Dow Jones notches new record, chip stocks leap higher - Yahoo Finance

Oct 17, 2024
pulisher
Oct 14, 2024

Marshall Wace LLP Acquires New Stake in ChromaDex Co. (NASDAQ:CDXC) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Profire Energy, Inc. (NASDAQ:PFIE) Shares Sold by Marshall Wace LLP - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Marshall Wace LLP Makes New Investment in Vivid Seats Inc. (NASDAQ:SEAT) - Defense World

Oct 14, 2024
pulisher
Oct 04, 2024

Venous Leg Ulcers Treatment Market value, Innovations Driving Market Evolution (2024-2036) - Third Eye News

Oct 04, 2024
pulisher
Oct 01, 2024

Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients - The Malaysian Reserve

Oct 01, 2024
pulisher
Sep 30, 2024

LPTXLeap Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Sep 30, 2024
pulisher
Sep 30, 2024

Venous Leg Ulcers Treatment Market Growth, Size, Research Report and Forecast (2024-2034) - Talented India

Sep 30, 2024
pulisher
Sep 28, 2024

Leap Therapeutics (NASDAQ:LPTX) Share Price Passes Below 50 Day Moving Average of $2.58 - MarketBeat

Sep 28, 2024
pulisher
Sep 25, 2024

Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR

Sep 25, 2024
pulisher
Sep 25, 2024

TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail

Sep 25, 2024
pulisher
Sep 20, 2024

Simplify Asset Management Inc. Has $1.24 Million Stock Position in Leap Therapeutics, Inc. (NASDAQ:LPTX) - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Simplify Asset Management Inc. Buys 255,293 Shares of Leap Therapeutics, Inc. (NASDAQ:LPTX) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Meiji Yasuda Asset Management Co Ltd. Has $1.22 Million Stock Position in Hilton Worldwide Holdings Inc. (NYSE:HLT) - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Commonwealth Equity Services LLC Boosts Position in AllianzIM U.S. Large Cap Buffer10 Sep ETF (NYSEARCA:SEPT) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Newmark Security (LON:NWT) Stock Price Crosses Above Two Hundred Day Moving Average of $91.75 - Defense World

Sep 19, 2024
pulisher
Sep 17, 2024

How Analyst Ratings Affect Leap Therapeutics Inc Inc. (LPTX) Price Performance - The InvestChronicle

Sep 17, 2024
pulisher
Sep 16, 2024

Second generation of I-SPY 2 TRIAL design is driving the “precise” in precision medicine - Yahoo Finance

Sep 16, 2024
pulisher
Sep 10, 2024

Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Leap 41% Yet They're Still Not Telling The Full Story - Simply Wall St

Sep 10, 2024
pulisher
Sep 06, 2024

Lilly adds to genetic meds push with Genetic Leap alliance - pharmaphorum

Sep 06, 2024
pulisher
Sep 05, 2024

Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs - Yahoo Finance

Sep 05, 2024
pulisher
Sep 05, 2024

Vera Therapeutics (NASDAQ:VERA) vs. Pivotal Therapeutics (OTCMKTS:PVTTF) Financial Analysis - Defense World

Sep 05, 2024
pulisher
Sep 03, 2024

Global Gastric Cancer Diagnostics Market is Expected to Expand at a CAGR of ~7% by 2030 | DelveInsight - PR Newswire UK

Sep 03, 2024
pulisher
Sep 03, 2024

ORKA Stock Price and Chart — NASDAQ:ORKA - TradingView

Sep 03, 2024
pulisher
Sep 02, 2024

Lululemon Athletica (NASDAQ:LULU) Price Target Lowered to $326.00 at Morgan Stanley - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Farther Finance Advisors LLC Has $1.20 Million Stake in Paychex, Inc. (NASDAQ:PAYX) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Laramide Resources Ltd. (TSE:LAM) Director Buys C$10,200.00 in Stock - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Buys Shares of 8,904 Capital Group Growth ETF (NYSEARCA:CGGR) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Picton Mahoney Asset Management Takes $71,000 Position in American Woodmark Co. (NASDAQ:AMWD) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Makes New Investment in iShares Core MSCI Europe ETF (NYSEARCA:IEUR) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Farther Finance Advisors LLC Has $1.36 Million Stake in McKesson Co. (NYSE:MCK) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Intel Co. (NASDAQ:INTC) Shares Purchased by Farther Finance Advisors LLC - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Takes Position in BlackRock MuniHoldings Quality Fund II, Inc. (NYSE:MUE) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

BNP PARIBAS ASSET MANAGEMENT Holding S.A. Trims Stock Holdings in Universal Health Services, Inc. (NYSE:UHS) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Allspring Global Investments Holdings LLC Sells 103,605 Shares of Wabash National Co. (NYSE:WNC) - Defense World

Sep 02, 2024
pulisher
Aug 31, 2024

Leap Therapeutics, Inc. (NASDAQ:LPTX) Short Interest Update - MarketBeat

Aug 31, 2024
pulisher
Aug 27, 2024

Sermonix Pharmaceuticals Completes Enrollment of Phase 2 - GlobeNewswire

Aug 27, 2024
pulisher
Aug 22, 2024

Atossa and Quantum Leap dose first subject in breast cancer therapy trial - Yahoo Finance

Aug 22, 2024
pulisher
Aug 22, 2024

Openwater Achieves Quantum Leap in Medicine: Harnesses Light, Sound, and Electromagnetics to Diagnose and Treat Diseases at Cellular Level - Yahoo Finance

Aug 22, 2024
pulisher
Aug 21, 2024

Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer - ForexTV.com

Aug 21, 2024
pulisher
Aug 20, 2024

Vanguard Group Inc. Buys 457,904 Shares of Leap Therapeutics, Inc. (NASDAQ:LPTX) - MarketBeat

Aug 20, 2024
pulisher
Aug 20, 2024

AstraZeneca (LON:AZN) Stock Price Crosses Above 200-Day Moving Average of $11,535.34 - Defense World

Aug 20, 2024
pulisher
Aug 20, 2024

Vanguard Group Inc. Acquires 156,044 Shares of Priority Technology Holdings, Inc. (NASDAQ:PRTH) - Defense World

Aug 20, 2024
pulisher
Aug 15, 2024

Analysts Issue Forecasts for Leap Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:LPTX) - MarketBeat

Aug 15, 2024
pulisher
Aug 15, 2024

Q3 2024 EPS Estimates for MiNK Therapeutics, Inc. (NASDAQ:INKT) Boosted by Analyst - Defense World

Aug 15, 2024

Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):